{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:44:20Z","timestamp":1790811860814,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.7759\/cureus.60338","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T11:37:43Z","timestamp":1715773063000},"source":"Crossref","is-referenced-by-count":2,"title":["Role of Intracoronary Adrenaline in the Treatment of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention"],"prefix":"10.7759","author":[{"given":"Leonard","family":"Simoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Gjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Ziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Dibra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artan","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne RA","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al.. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023, 44:3720-826. 10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley EC","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003, 361:13-20. 10.1016\/S0140-6736(03)12113-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.793745","article-title":"Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies","volume":"119","author":"Huynh T","year":"2009","unstructured":"Huynh T, Perron S, O'Loughlin J, Joseph L, Labrecque M, Tu JV, Th\u00e9roux P. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation. 2009, 119:3101-9. 10.1161\/CIRCULATIONAHA.108.793745","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.11.059","article-title":"Management of no-reflow phenomenon in the catheterization laboratory","volume":"10","author":"Rezkalla SH","year":"2017","unstructured":"Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv. 2017, 10:215-23. 10.1016\/j.jcin.2016.11.059","journal-title":"JACC Cardiovasc Interv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.03.359","article-title":"Novel insights into an \"old\" phenomenon: the no reflow","volume":"187","author":"Durante A","year":"2015","unstructured":"Durante A, Camici PG. Novel insights into an \"old\" phenomenon: the no reflow. Int J Cardiol. 2015, 187:273-80. 10.1016\/j.ijcard.2015.03.359","journal-title":"Int J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"55","author":"Ndrepepa G","year":"2010","unstructured":"Ndrepepa G, Tiroch K, Fusaro M, et al.. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010, 55:2383-9. 10.1016\/j.jacc.2009.12.054","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20183","article-title":"Importance of tissue perfusion in ST segment elevation myocardial infarction patients undergoing reperfusion strategies: role of adenosine","volume":"30","author":"Forman MB","year":"2007","unstructured":"Forman MB, Jackson EK. Importance of tissue perfusion in ST segment elevation myocardial infarction patients undergoing reperfusion strategies: role of adenosine. Clin Cardiol. 2007, 30:583-5. 10.1002\/clc.20183","journal-title":"Clin Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2006.00116.x","article-title":"Role of adenosine as adjunctive therapy in acute myocardial infarction","volume":"24","author":"Forman MB","year":"2006","unstructured":"Forman MB, Stone GW, Jackson EK. Role of adenosine as adjunctive therapy in acute myocardial infarction. Cardiovasc Drug Rev. 2006, 24:116-47. 10.1111\/j.1527-3466.2006.00116.x","journal-title":"Cardiovasc Drug Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/382086","article-title":"Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials","volume":"2015","author":"Wang L","year":"2015","unstructured":"Wang L, Cheng Z, Gu Y, Peng D. Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials. Biomed Res Int. 2015, 2015:382086. 10.1155\/2015\/382086","journal-title":"Biomed Res Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20885","article-title":"Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention","volume":"68","author":"Huang RI","year":"2006","unstructured":"Huang RI, Patel P, Walinsky P, et al.. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006, 68:671-6. 10.1002\/ccd.20885","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-013-9690-9","article-title":"Safety and effectiveness of nitroprusside in preventing no-reflow during percutaneous coronary intervention: a systematic review","volume":"68","author":"Su Q","year":"2014","unstructured":"Su Q, Li L, Naing KA, Sun Y. Safety and effectiveness of nitroprusside in preventing no-reflow during percutaneous coronary intervention: a systematic review. Cell Biochem Biophys. 2014, 68:201-6. 10.1007\/s12013-013-9690-9","journal-title":"Cell Biochem Biophys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/joic.12133","article-title":"Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis","volume":"27","author":"Zhao S","year":"2014","unstructured":"Zhao S, Qi G, Tian W, Chen L, Sun Y. Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis. J Interv Cardiol. 2014, 27:356-64. 10.1111\/joic.12133","journal-title":"J Interv Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.150888","article-title":"Role of adrenergic receptors in human coronary vasomotion","volume":"95","author":"Barbato E","year":"2009","unstructured":"Barbato E. Role of adrenergic receptors in human coronary vasomotion. Heart. 2009, 95:603-8. 10.1136\/hrt.2008.150888","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.08.052","article-title":"Cardiac arrest with coronary artery spasm: does the use of epinephrine during cardiopulmonary arrest exacerbate the spasm?","volume":"33","author":"Zhang ZP","year":"2015","unstructured":"Zhang ZP, Su X, Yang YC, Wu MX, Liu B, Liu CW. Cardiac arrest with coronary artery spasm: does the use of epinephrine during cardiopulmonary arrest exacerbate the spasm?. Am J Emerg Med. 2015, 33:479.e5-6. 10.1016\/j.ajem.2014.08.052","journal-title":"Am J Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10303","article-title":"Resolution of refractory no-reflow with intracoronary epinephrine","volume":"57","author":"Skelding KA","year":"2002","unstructured":"Skelding KA, Goldstein JA, Mehta L, Pica MC, O'Neill WW. Resolution of refractory no-reflow with intracoronary epinephrine. Catheter Cardiovasc Interv. 2002, 57:305-9. 10.1002\/ccd.10303","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-015-0004-6","article-title":"Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study","volume":"15","author":"Aksu T","year":"2015","unstructured":"Aksu T, Guler TE, Colak A, Baysal E, Durukan M, Sen T, Guray U. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2015, 15:10. 10.1186\/s12872-015-0004-6","journal-title":"BMC Cardiovasc Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29113","article-title":"Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study","volume":"97","author":"Navarese EP","year":"2021","unstructured":"Navarese EP, Frediani L, Kandzari DE, et al.. Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study. Catheter Cardiovasc Interv. 2021, 97:602-11. 10.1002\/ccd.29113","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2022.75","article-title":"Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study","volume":"42","author":"Darwish A","year":"2022","unstructured":"Darwish A, Frere AF, Abdelsamie M, Awady WE, Gouda M. Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study. Ann Saudi Med. 2022, 42:75-82. 10.5144\/0256-4947.2022.75","journal-title":"Ann Saudi Med"},{"key":"ref19","article-title":"Intracoronary verapamil vs. intracoronary epinephrine in the management of coronary no reflow during primary percutaneous coronary intervention","volume":"14","author":"Hafez MG","year":"2021","unstructured":"Hafez MG, Ghazawy AR, Zahran MS. Intracoronary verapamil vs. intracoronary epinephrine in the management of coronary no reflow during primary percutaneous coronary intervention. Interv Cardiol. 2021, 14:436-43.","journal-title":"Interv Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011408","article-title":"Comparison of Intracoronary epinephrine and adenosine for no-reflow in normotensive patients with acute coronary syndrome (COAR Trial)","volume":"15","author":"Khan KA","year":"2022","unstructured":"Khan KA, Qamar N, Saghir T, et al.. Comparison of Intracoronary epinephrine and adenosine for no-reflow in normotensive patients with acute coronary syndrome (COAR Trial). Circ Cardiovasc Interv. 2022, 15:e011408. 10.1161\/CIRCINTERVENTIONS.121.011408","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253704-role-of-intracoronary-adrenaline-in-the-treatment-of-no-reflow-phenomenon-in-patients-undergoing-percutaneous-coronary-intervention","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T11:37:46Z","timestamp":1715773066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253704-role-of-intracoronary-adrenaline-in-the-treatment-of-no-reflow-phenomenon-in-patients-undergoing-percutaneous-coronary-intervention"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.60338","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}